A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease

NCT06175767 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD

NCT00209508 ·Status: COMPLETED ·Phase: PHASE2

A Study of KW-6356 in Subjects With Early Parkinson's Disease

NCT02939391 ·Status: COMPLETED ·Phase: PHASE2

First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders

NCT02719197 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

NCT03068481 ·Status: COMPLETED ·Phase: PHASE1

A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations

NCT03703570 ·Status: COMPLETED ·Phase: PHASE2

First-in-man Study of Single and Multiple Ascending Doses of a New Drug for Neurological Disorders

NCT02702648 ·Status: COMPLETED ·Phase: PHASE1

A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients

NCT00537485 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

NCT06189170 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease

NCT02373072 ·Status: COMPLETED ·Phase: PHASE1

A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients

NCT02337725 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

NCT00286897 ·Status: COMPLETED ·Phase: PHASE3

Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia

NCT04912115 ·Status: SUSPENDED ·Phase: PHASE2

A Study of MK0657 in Parkinson's Disease Patients (0657-006)

NCT00505843 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

NCT03845387 ·Status: COMPLETED ·Phase: PHASE2

Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)

NCT00385710 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's Disease

NCT03716570 ·Status: TERMINATED ·Phase: PHASE1

A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects

NCT03830528 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

NCT03670953 ·Status: COMPLETED ·Phase: PHASE3

A Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parkinson's Disease (PD)

NCT04651153 ·Status: COMPLETED ·Phase: PHASE1

A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients

NCT01628848 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia

NCT03176771 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients

NCT02073981 ·Status: COMPLETED

Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects

NCT04165837 ·Status: COMPLETED ·Phase: PHASE1

Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease

NCT00623363 ·Status: COMPLETED ·Phase: PHASE2